Unmet Need in Retinal Disease Delivery Systems:
There is a tremendous unmet medical need in delivery systems for protein therapies for back of the eye diseases such as macular degeneration and associated conditions
A multitude of new protein therapies are being developed for retinal diseases
The current standard of care is a monthly injection into the back of the eye by an ophthalmologist specializing in retinal disease (e.g. Lucentis, Eylea)